Question 1

What is the catalog number for BI-D1870?

Accepted Answer

The catalog number for BI-D1870 is M14686.

Question 2

What sizes are available for BI-D1870?

Accepted Answer

BI-D1870 is available in the following size(s): 1 g, 200 mg, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does BI-D1870 come in?

Accepted Answer

BI-D1870 is available in 8 different pack sizes.

Question 4

Is BI-D1870 in stock?

Accepted Answer

BI-D1870 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is BI-D1870 used for?

Accepted Answer

BI-D1870 is an ATP-competitive inhibitor of S6 ribosome for RSK1/2/3/4 with IC50 of 31 nM/24 nM/18 nM/15 nM, respectively.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 8

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

BI-D1870

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

CAB39L Human Over-expression Lysate

Lentiviral human CCDC167 sgRNA gene knockout kit - Lentiviral human CCDC167 sgRNA gene knockout kit (plasmid)

MCM6 discontinued

Kidney tumor tissue array with matched tumor adjacent kidney tissue, including TNM, clinical stage and pathology grade, 65 cases/260 coresï¼Œreplacing KD2602

KRT5 siRNA (Rat)

KRT5 siRNA (Rat)